Results of the first Russian multicenter non-interventional study of Contour® TS glucometer

Cover Page

Cite item

Full Text

Abstract

Aim. To evaluate fitness of Contour® TS glucometer (Contour® TS, Bayer/Ascensia*) - a system for blood glycemia level control, and its characteristics in everyday use for Russian patients with insulin dependent diabetes mellitus (DM) types 1 and 2 and endocrinologists. Study design. According to the inclusion criteria, 3759 patients were registered in the program, of which 3599 patients have completed the study as per 3 visits. The non-interventional study was conducted in 84 medical centers in RF during the period from October 2013 to June 2015. Age of insulin-dependent patients and patients on hypoglycaemic therapy was 18 years and older. Results. Observational program included - 1126 (31.29%) patients with type 1 diabetes mellitus and 2473 (68.71%) patients with type 2 diabetes mellitus. Following switch to Contour® TS, while insulin therapy regimens were maintained, it was noted that the rate of blood glucose measurement increased compared with Visit 1 (p<0.0001). Upon assessment of satisfaction with the device, virtually all questions were answered as “good” and “perfect” by more than 90% patients and 95% study doctors. Upon assessment of the quality of life by EQ-5D, increase of this parameter was noted in 6 months, at Visit 3 (p<0.0001). No glucometer-associated malfunction were registered during the study. Additional data from general clinical experience of each patient that allowed to establish significant reduction of the levels of glycosilated haemoglobin and pre-prandial blood glucose just in 3 months at Visit 2, significant reduction of reported hypoglycaemia episodes as calculated per one patient have been obtained during the study. Additional data on the prevalence of macro- and microvascular complications were obtained during the study, and the highest per cent was for non-proliferative retinopathy and nephropathy at the stage of albuminuria. The most common among concomitant diseases were arterial hypertension, dyslipidemia and coronary artery disease. Conclusion. Use of Contour® TS glucometer by the patients, while insulin therapy regimens were maintained, led to increase in the rate of blood glucose measurements by up to 4-6 times during the day and statistically significant improvement in blood glucose control.

About the authors

Marina V. Shestakova

Endocrinology Research Centre

Email: nephro@endocrincentr.ru
Acad. RAS, D. Sci. (Med.), Full Prof.

Liubov L. Bolotskaya

Federal Diabetes Register, Endocrinology Research Centre

Email: BolotskayaLiubov@gmail.com
Cand. Sci. (Med.), Endocrinologist

Mariia V. Verbovaia

Center "Diabetes"

Email: mverbovaya@rambler.ru
Cand. Sci. (Med.), Endocrinologist

Marina R. Lukina

Kursk Regional Clinical Hospital

Email: lukinamr@mail.ru
Endocrinologist

Elena G. Rykova

Medical Rehabilitation Center, Belgorod Regional Clinical Hospital of St. Joasaph

Email: elena_belgorod@bk.ru
Endocrinologist

Ekaterina O. Ten

City Polyclinic №94

Email: Tenek@mail.ru
Endocrinologist

Nina V. Kupriianova-Ashina

Outpatient Department of Diabetes Center, Republican Clinical Hospital

Email: kupriyanova-ashina@mail.ru
Endocrinologist

Ekaterina S. Tiunova

Private Clinic Salon "Roden"

Email: jigalova.ek@mail.ru
Endocrinologist

Elena A. Zhdanova

Voronezh Regional Clinical Consulting and Diagnostic Center

Cand. Sci. (Med.), Endocrinologist

Lala Iu. Shabanova

Road Clinical Hospital at station Rostov-Glavnyj

Cand. Sci. (Med.), Endocrinologist

Natalia Iu. Taradaiko

N.A.Semashko Nizhny Novgorod Regional Clinical Hospital

Email: 127natalya127@gmail.com
Endocrinologist

Anna S. Malishevskaia

Sverdlovsk Regional Clinical Hospital №1

Email: avine@mail.ru
Endocrinologist

Alla A. Vachugova

Volgograd Regional Clinical Hospital №1

Email: Avachugova@yandex.ru
Endocrinologist

Karine V. Sogomonian

City Polyclinic №52

Endocrinologist

References

  1. Алгоритмы специализированной медицинской помощи больным сахарным диабетом в Российской Федерации. Вып. 8. М., 2017; с. 42-4.
  2. Майоров А.Ю., Суркова Е.В., Мельникова О.Г. Сахарный диабет 1 типа. Руководство для пациентов. М., 2016; c. 21-3.
  3. Nathan D.M, for the DCCT/EDIC Research Group. The Diabetes Control and Complication Trial/Epidemiology of Diabetes Interventions and Complications study at 30 years: overview. Diabetes Care 2014; 37: 9-16.
  4. The journal of clinical and applied research and Education. American Diabetes Association. Standards of medical care in diabetes 2017. Diabetes Care 2017; 40 (Suppl. 1): 548-56. DOI: 10.2337 / dc175009 2009
  5. Rodbard H.W, Blonde L, Braithwaite S.S et al. AACE Diabetes Mellitus Clinical Practice Guidelines Task Force American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2007; 13 (Suppl. 1): 1-68.
  6. Frank J, Wallace J.F, Pardo S et al. Performance of the CONTOUR® TS Blood Glucose Monitoring System. J Diabetes Sci Technol 2011; 5 (1).
  7. Caswell M, Frank J, Viggiani M.T et al. Accuracy and User Performance Evaluation of a Blood Glucose Monitoring System DTT 2015; 17 (Suppl. 3): 152-8.
  8. Franciosi M, Lucisano G, Pellegrini F et al. ROSES: role of self-monitoring of blood glucose and intensive education in patients with type 2 diabetes not receiving insulin. A pilot randomized clinical trial. Diabet Med 2011; 28: 789-96.
  9. Polonsky W.H, Fisher L, Schikman C.H et al. Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes. Results from the Structured. Testing Program study. Diabetes Care 2011; 34 (2): 262-7.
  10. Fera T, Bluml B.M, Ellis W.M. Diabetes ten city challenge: final economic and clinical results. J Am Pharm Assoc 2009; 49: 383-91.
  11. Karter A.J, Ackerson L.M, Darbinian J.A et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes Registry. Am J Med 2001; 111: 1-9.
  12. Сунцов Ю.И., Дедов И.И., Шестакова М.В. Скрининг осложнений сахарного диабета как метод оценки качества лечебной помощи больным. Министерство здравоохранения и социального развития России Федерации, ФГБУ «Научный центр эндокринологии». 2008.

Copyright (c) 2019 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies